Topic: News & Events

April 2024

AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis

https://www.lupuscanada.org/wp-content/uploads/AZD1222_PhIII-US-HLR_RNS.pdf

< Back to Main List Next Article >

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Exploring Cognitive Fatigue and Brain Function in Lupus: New MRI Study Reveals Insights into Cognitive Impairment Mechanisms

Catalyst Grant News & Events

Scientists say they have identified a root cause of lupus — one that could pave the way for new treatments

Advocacy & Support Community & Awareness

Belimumab (Benlysta) Now Approved in Saskatchewan, Nova Scotia, and New Brunswick for Lupus Nephritis

Advocacy & Support Community & Awareness